Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H23N3O2 |
InChIKeyDRKXYVLEIYLCPW-UHFFFAOYSA-N |
CAS Registry685884-37-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 01 Mar 2021 |